Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK   DE0006599905


News SummaryMost relevantAll newsSector news 

Merck KGaA May Withdraw Research from Portugal over Debt-Report

07/09/2012 | 02:28am US/Eastern

German chemical company Merck KGaA (>> Merck KGaA) may withdraw future investments for research projects in Portugal worth tens of millions of euros unless the government hospitals stick to the agreed-upon debt repayments, German daily newspaper Financial Times Deutschland reports Monday.

Merck Portugal's manager Fritz Sacher told the paper the company's research projects are long-term and require mutual trust as a basis. "The Portuguese government's lacking payment habits undermine this trust," he is quoted as saying.

Portuguese government hospitals owe the pharmaceutical industry a total of more than 1.5 billion euros ($1.84 billion) and companies have to wait nearly 550 days on average until invoices are paid, FTD reports.

Some companies, including Roche Holding AG (ROG.VX), have already halted the sale of medications on credit to highly indebted countries like Portugal, Greece, Spain and Italy until outstanding debts are paid, the paper notes, but for many companies such drastic steps are difficult as they carry responsibility for people's wellbeing.

Withdrawing research projects is a way of putting pressure on the government, as Portugal is an attractive location for research investments, FTD says. "The conditions for certain research and human studies are as good as in the U.S., but it's significantly more cost-effective in Portugal," Sacher told the paper.

Newspaper website:

Write to the Frankfurt Bureau at

Stocks mentioned in the article : Merck KGaA
React to this article
Latest news on MERCK KGAA
07:37a MERCK KGAA : EMD Millipore Assigned Patent
04:06a MERCK KGAA : Leads European Research Consortium on Printed Electronics
02:53a PFIZER : Merck KGaA :, Darmstadt, Germany, and Pfizer to Present Data at ASCO fo..
05/21 MERCK KGAA : Millipore Introduces Single-Pass Tangential Flow Filtration with Pe..
05/21 MERCK KGAA : Millipore Enters Into Agreement to Acquire Exclusive Rights to Sing..
05/21 MERCK KGAA : Release according to Article 26, Section 1 of the WpHG with the obj..
05/20 MERCK KGAA : Darmstadt, Germany, and Pfizer to Present Data at ASCO for Avelumab..
05/20 MERCK KGAA : For Displays and More: Merck Presents Expanded Portfolio and New De..
05/19DJMerck Profit Pressured by Financing for Sigma-Aldrich Deal -- Update
05/19DJMerck Profit Pressured by M&A Financing
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes